目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
2.2.1.2 Approach 2: Customer-based market estimation
2.2.1.3 Approach 3: Top-down approach
2.2.1.4 Approach 4: Primary interviews
2.3 DATA TRIANGULATION & MARKET BREAKDOWN
2.4 MARKET SHARE ASSESSMENT
2.5 STUDY ASSUMPTIONS
2.6 GROWTH RATE ASSUMPTIONS/MARKET FORECASTING METHODOLOGY
2.7 LIMITATIONS
2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 ULTRASOUND MARKET OVERVIEW
4.2 ULTRASOUND MARKET, BY REGION, 2022-2030
4.3 EUROPE: ULTRASOUND MARKET, BY REGION AND END USER, 2023
4.4 GEOGRAPHIC SNAPSHOT OF ULTRASOUND MARKET

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of chronic diseases
5.2.1.2 Rising patient preference for minimally invasive surgeries
5.2.1.3 Rising technological advancements in ultrasound devices
5.2.1.4 Growing public and private investments, funding, and grants
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable reimbursements
5.2.2.2 High operating costs
5.2.3 OPPORTUNITIES
5.2.3.1 Growing applications of therapeutic ultrasound
5.2.3.2 Growth in emerging markets
5.2.3.3 Development of POC ultrasound devices
5.2.4 CHALLENGES
5.2.4.1 Growing end-user preference for refurbished equipment
5.2.4.2 Shortage of skilled sonographers
5.3 INDUSTRY TRENDS
5.3.1 ENDOSCOPIC ULTRASOUND
5.3.2 WIRELESS AND PORTABLE SYSTEMS
5.4 VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
5.5.1 PROMINENT COMPANIES
5.5.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.5.3 END USERS
5.6 PORTER'S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 BARGAINING POWER OF SUPPLIERS
5.6.3 BARGAINING POWER OF BUYERS
5.6.4 THREAT OF SUBSTITUTES
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 KEY STAKEHOLDERS & BUYING CRITERIA
5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.7.2 BUYING CRITERIA
5.8 PATENT ANALYSIS
5.9 TRADE DATA ANALYSIS
5.9.1 IMPORT DATA
5.9.2 EXPORT DATA
5.10 KEY CONFERENCES & EVENTS, 2024-2025
5.11 UNMET NEEDS AND KEY PAIN POINTS
5.12 ECOSYSTEM ANALYSIS
5.13 IMPACT OF GEN AI ON ULTRASOUND MARKET
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.15 TECHNOLOGY ANALYSIS
5.15.1 KEY TECHNOLOGIES
5.15.1.1 Contrast-enhanced ultrasound (CEUS)
5.15.1.2 Portable and handheld ultrasound devices
5.15.2 COMPLEMENTARY TECHNOLOGIES
5.15.2.1 Elastography
5.15.2.2 Fluoroscopy
5.15.3 ADJACENT TECHNOLOGIES
5.15.3.1 PET/CT
5.16 CASE STUDY ANALYSIS
5.16.1 LARGE-DIAMETER LUMEN-APPOSING METAL STENTS FOR WALLED-OFF NECROSIS
5.16.2 PRENATAL DIAGNOSIS OF HYPOPHOSPHATASIA CONGENITAL USING ULTRASONOGRAPHY
5.16.3 POSTOPERATIVE PERIRECTAL ABSCESS DRAINAGE
5.17 REGULATORY ANALYSIS
5.17.1 NORTH AMERICA
5.17.1.1 US
5.17.1.2 Canada
5.17.2 EUROPE
5.17.3 ASIA PACIFIC
5.17.3.1 Japan
5.17.3.2 China
5.17.3.3 India
5.17.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.18 INVESTMENT & FUNDING SCENARIO
5.19 PRICING ANALYSIS
5.19.1 AVERAGE SELLING PRICE TREND, BY REGION
5.19.2 AVERAGE SELLING PRICE FOR TOP 3 APPLICATIONS, BY KEY PLAYER
5.20 REIMBURSEMENT SCENARIO

6 ULTRASOUND MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
6.2 DIAGNOSTIC ULTRASOUND
6.2.1 2D ULTRASOUND
6.2.1.1 Growing demand for minimally invasive surgeries to increase use of 2D ultrasound
6.2.2 3D & 4D ULTRASOUND
6.2.2.1 Improved diagnosis with 3D ultrasound technology to boost market growth
6.2.3 DOPPLER ULTRASOUND
6.2.3.1 Growing applications in cardiology and vascular to drive market growth
6.2.4 CONTRAST-ENHANCED ULTRASOUND
6.2.4.1 Enhanced diagnostic imaging with advanced ultrasound systems to boost demand
6.3 THERAPEUTIC ULTRASOUND
6.3.1 HIGH-INTENSITY-FOCUSED ULTRASOUND
6.3.1.1 Advancing cancer treatment with HIFU to fuel growth
6.3.2 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY
6.3.2.1 Enhancing urolithiasis treatment with advanced ESWL techniques and technologies to propel market

7 ULTRASOUND MARKET, BY DISPLAY
7.1 INTRODUCTION
7.2 COLOR ULTRASOUND
7.2.1 GROWING DEMAND FOR COLOR ULTRASOUND TO SUPPORT MARKET GROWTH
7.3 BLACK & WHITE ULTRASOUND
7.3.1 ENHANCED DIAGNOSTIC PRECISION WITH B/W ULTRASOUND TO DRIVE DEMAND

8 ULTRASOUND MARKET, BY PORTABILITY
8.1 INTRODUCTION
8.2 TROLLEY/CART-BASED ULTRASOUND SYSTEMS
8.2.1 IMPROVED PATIENT EXPERIENCE WITH TROLLEY-BASED ULTRASOUND SYSTEMS TO DRIVE MARKET GROWTH
8.3 COMPACT/HANDHELD ULTRASOUND SYSTEMS
8.3.1 GROWING NUMBER OF TRAUMA/EMERGENCY CASES TO FUEL MARKET GROWTH
8.4 POC ULTRASOUND DEVICES
8.4.1 IMPROVED OPERATIONAL AND CLINICAL EFFICACY TO BOOST DEMAND FOR POC ULTRASOUND DEVICES

9 ULTRASOUND MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 RADIOLOGY/GENERAL IMAGING
9.2.1 GROWING NUMBER OF CHRONIC DISEASES LEADING TO INCREASED USE OF THIS APPLICATION
9.3 CARDIOLOGY
9.3.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASE ACROSS MAJOR HEALTHCARE MARKETS TO DRIVE GROWTH
9.4 OB/GYN
9.4.1 WIDE ADOPTION OF AI IN ULTRASOUND IN FIELD OF OB/GYN TO BOOST MARKET
9.5 UROLOGY
9.5.1 WIDE USE OF ULTRASOUND IN DIAGNOSIS AND TREATMENT OF VARIOUS UROLOGICAL DISORDERS TO DRIVE MARKET
9.6 VASCULAR
9.6.1 VASCULAR APPLICATIONS SEGMENT TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
9.7 ORTHOPEDIC & MUSCULOSKELETAL
9.7.1 RISING PREVALENCE OF OSTEOARTHRITIS TO DRIVE MARKET GROWTH
9.8 PAIN MANAGEMENT
9.8.1 GROWING ADOPTION OF PORTABLE ULTRASOUND FOR PAIN MANAGEMENT TO SUPPORT GROWTH
9.9 PEDIATRIC
9.9.1 GROWING USE OF PEDIATRIC ULTRASOUND TO COMBAT NEONATAL MORTALITY TO SPUR GROWTH
9.10 OTHER APPLICATIONS

10 ULTRASOUND MARKET, BY COMPONENT
10.1 INTRODUCTION
10.2 TRANSDUCERS/PROBES
10.2.1 CURVILINEAR/CONVEX ARRAY PROBES
10.2.1.1 Enhanced diagnosis with curvilinear and convex array ultrasound probes to boost market
10.2.2 LINEAR ARRAY PROBES
10.2.2.1 High-resolution power with linear array ultrasound systems to drive demand
10.2.3 PHASED ARRAY PROBES
10.2.3.1 Advanced imaging capabilities to drive market growth
10.2.4 OTHER PROBES
10.3 WORKSTATIONS
10.3.1 INCREASE IN DIAGNOSTIC PROCEDURES TO PROPEL DEMAND FOR WORKSTATIONS
10.4 OTHER COMPONENTS

11 ULTRASOUND MARKET, BY END USER
11.1 INTRODUCTION
11.2 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS
11.2.1 INCREASING PREVALENCE OF CANCER TO BOOST MARKET GROWTH
11.3 MATERNITY CENTERS
11.3.1 INCREASED ADOPTION OF ADVANCED ULTRASOUND SYSTEMS FOR OB/GYN APPLICATIONS TO DRIVE MARKET GROWTH
11.4 AMBULATORY CENTERS
11.4.1 INCREASING NUMBER OF SURGERIES TO PROPEL MARKET GROWTH
11.5 RESEARCH & ACADEMIC INSTITUTES
11.5.1 GROWING NUMBER OF RESEARCH GRANTS TO BOOST MARKET GROWTH
11.6 OTHER END USERS

12 ULTRASOUND MARKET, BY REGION
12.1 INTRODUCTION
12.2 EUROPE
12.2.1 MACROECONOMIC OUTLOOK FOR EUROPE
12.2.2 GERMANY
12.2.2.1 Growing healthcare expenditures and grants to drive market
12.2.3 FRANCE
12.2.3.1 Increasing population and rising number of centers to drive market
12.2.4 UK
12.2.4.1 Increasing prevalence of chronic diseases to contribute to market growth
12.2.5 ITALY
12.2.5.1 Increased availability of reimbursement coverage for diagnostic procedures to drive market
12.2.6 SPAIN
12.2.6.1 Growing focus on cancer research to support market growth
12.2.7 REST OF EUROPE
12.3 NORTH AMERICA
12.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.3.2 US
12.3.2.1 Rise in cancer prevalence to drive market
12.3.3 CANADA
12.3.3.1 New product launches & conferences to drive market
12.4 ASIA PACIFIC
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2 CHINA
12.4.2.1 Increasing acquisitions and partnerships to drive market
12.4.3 JAPAN
12.4.3.1 Established healthcare infrastructure and research facilities to drive market
12.4.4 INDIA
12.4.4.1 Government initiatives to drive market
12.4.5 AUSTRALIA
12.4.5.1 Growing healthcare spending and increasing investments in research to drive market
12.4.6 SOUTH KOREA
12.4.6.1 Well-developed healthcare system and conferences to drive market
12.4.7 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2 BRAZIL
12.5.2.1 Greater purchasing power and favorable demographic conditions to drive market
12.5.3 MEXICO
12.5.3.1 Increased medical tourism and better government healthcare initiatives to drive market
12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 GROWING QUALITY HEALTHCARE SYSTEMS TO DRIVE MARKET
12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.3 GCC COUNTRIES
12.6.3.1 Developments in investment approach to drive market
12.6.4 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ULTRASOUND MARKET
13.3 REVENUE ANALYSIS, 2019-2023
13.4 MARKET SHARE ANALYSIS, 2023
13.4.1 RANKING OF KEY MARKET PLAYERS
13.5 COMPANY EVALUATION MATRIX: DIAGNOSTIC ULTRASOUND MARKET (KEY PLAYERS), 2023
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Technology footprint
13.5.5.4 Display footprint
13.5.5.5 Portability footprint
13.5.5.6 Component footprint
13.5.5.7 Application footprint
13.5.5.8 End-user footprint
13.6 COMPANY EVALUATION MATRIX: THERAPEUTIC ULTRASOUND MARKET (STARTUPS/SMES), 2023
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
13.7 COMPANY VALUATION & FINANCIAL METRICS
13.7.1 FINANCIAL METRICS
13.7.2 COMPANY VALUATION
13.8 BRAND/PRODUCT COMPARISON
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES & APPROVALS
13.9.2 DEALS

14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 GE HEALTHCARE
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Product launches, approvals, and upgrades
14.1.1.3.2 Deals
14.1.1.3.3 Other developments
14.1.1.4 MnM view
14.1.1.4.1 Right to win
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 PHILIPS HEALTHCARE
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Product launches & approvals
14.1.2.3.2 Deals
14.1.2.4 MnM view
14.1.2.4.1 Right to win
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses & competitive threats
14.1.3 CANON MEDICAL SYSTEMS CORPORATION
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 Recent developments
14.1.3.3.1 Product launches
14.1.3.3.2 Deals
14.1.3.3.3 Expansions
14.1.3.4 MnM view
14.1.3.4.1 Right to win
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses & competitive threats
14.1.4 SIEMENS HEALTHINEERS AG
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 Recent developments
14.1.4.3.1 Product launches
14.1.4.3.2 Deals
14.1.4.3.3 Expansions
14.1.4.4 MnM view
14.1.4.4.1 Right to win
14.1.4.4.2 Strategic choices
14.1.4.4.3 Weaknesses & competitive threats
14.1.5 FUJIFILM CORPORATION
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.3.1 Product launches
14.1.5.3.2 Deals
14.1.5.3.3 Expansions
14.1.5.4 MnM view
14.1.5.4.1 Right to win
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses & competitive threats
14.1.6 HOLOGIC, INC.
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.6.3 Recent developments
14.1.6.3.1 Product launches
14.1.6.3.2 Deals
14.1.6.3.3 Expansions
14.1.7 SAMSUNG ELECTRONICS CO., LTD.
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.7.3 Recent developments
14.1.7.3.1 Product launches
14.1.7.3.2 Deals
14.1.7.3.3 Other developments
14.1.8 MINDRAY MEDICAL INTERNATIONAL LIMITED
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Product launches
14.1.8.3.2 Deals
14.1.9 ESAOTE SPA
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.9.3 Recent developments
14.1.9.3.1 Product launches
14.1.9.3.2 Deals
14.1.10 CHISON MEDICAL TECHNOLOGIES CO., LTD.
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.10.3 Recent developments
14.1.10.3.1 Product launches
14.1.10.3.2 Deals
14.1.11 NEUSOFT MEDICAL SYSTEMS CO., LTD.
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.11.3 Recent developments
14.1.11.3.1 Product launches
14.1.12 KONICA MINOLTA, INC
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.13 CLARIUS
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.13.3 Recent developments
14.1.13.3.1 Product launches
14.1.13.3.2 Deals
14.1.14 MEDGYN PRODUCTS, INC.
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.15 PROMED TECHNOLOGY CO., LTD.
14.1.15.1 Business overview
14.1.15.2 Products offered
14.2 OTHER COMPANIES
14.2.1 WHITE EAGLE SONIC TECHNOLOGIES, INC.
14.2.2 SHENZHEN RICSO TECHNOLOGY CO., LTD.
14.2.3 YOUKEY MEDICAL
14.2.4 SIUI
14.2.5 TELEMED, MEDICAL IMAGING EQUIPMENT DESIGN & MANUFACTURING
14.2.6 BUTTERFLY NETWORK, INC.
14.2.7 ALPINION MEDICAL SYSTEMS
14.2.8 EDAN INSTRUMENTS, INC.
14.2.9 SHENZHEN LANDWIND INDUSTRY CO., LTD.
14.2.10 ECHONOUS INC.
14.2.11 MOBISANTE, INC.
14.2.12 SHENZHEN WISONIC MEDICAL TECHNOLOGY CO., LTD.
14.2.13 SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT CO., LTD.
14.2.14 SONOSCAPE MEDICAL CORP.
14.2.15 CURA HEALTHCARE

15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS